Document Detail

Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.
MedLine Citation:
PMID:  22339195     Owner:  NLM     Status:  In-Data-Review    
Pseudomonas aeruginosa is a highly successful opportunistic pathogen that displays intrinsic multidrug resistance and has a tremendous capacity to acquire further resistance mechanisms. During chronic infection, the bacterium can form a protective biofilm therefore reducing the efficacy of existing antibiotics. P. aeruginosa also harbors an impressive range of virulence factors, many of which are controlled by the quorum-sensing system. Several novel therapeutics are under investigation such as those directed against biofilm formation and quorum-sensing systems along with bacteriophages and immunotherapies. Recent advances in next-generation sequencing and comparative genomics have opened the door to a new wave of smart drug design that could revolutionize P. aeruginosa treatment options.
Joanne L Fothergill; Craig Winstanley; Chloe E James
Related Documents :
22695865 - Does dithiothreitol improve bacterial detection from infected prostheses? a pilot study.
8886865 - Endodontic failures--changing the approach.
20952425 - Mechanical thrombectomy of an infected deep venous thrombosis: a novel technique of sou...
23617365 - A case of multifocal choroiditis secondary to candida albicans infection in a leukemic ...
10993185 - Effects of autogenous toxoid-bacterin in lactating cows with staphylococcus aureus subc...
12648325 - Facial paralysis caused by tuberculosis in a 2.5-month-old infant.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of anti-infective therapy     Volume:  10     ISSN:  1744-8336     ISO Abbreviation:  Expert Rev Anti Infect Ther     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101181284     Medline TA:  Expert Rev Anti Infect Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  219-35     Citation Subset:  IM    
NIHR Biomedical Research Centre in Microbial Disease, University of Liverpool, Daulby Street, Liverpool, L69 3GA, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
Next Document:  Preventive chemotherapy and the fight against neglected tropical diseases.